| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |